In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients
Sci Rep. 2025 Nov 27;15(1):42373. doi: 10.1038/s41598-025-26411-4. ABSTRACT Medulloblastoma is the most common malignant pediatric brain tumor. Survival rates vary widely between subgroups, with an …